Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024)

Ani Pharmaceuticals (ANIP) posted Acquisitions of $8.2 million for Q4 2024, down 90.29% sequentially from $84.5 million in Q4 2021.

Ani Pharmaceuticals (ANIP) Acquisitions (2018 - 2024) Analysis & Trends

Ani Pharmaceuticals has reported Acquisitions for 3 years, with the latest figure at $8.2 million in Q4 2024.

Quarterly Acquisitions changed N/A year-over-year to $8.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $8.2 million (changed 0.0% YoY) and the FY2024 annual result came in at $401.3 million, changed N/A from the prior year.
Acquisitions eased to $8.2 million in Q4 2024 per ANIP's latest filing, from $84.5 million in the prior quarter.
Over five years, Acquisitions peaked at $84.5 million in Q4 2021 and troughed at $8.2 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Ani Pharmaceuticals	1.63 Bn	1.27 Bn	165.89 Mn	-

Download Data